Back to search

Article

Activity of Telavancin against <i>S. aureus</i> isolated from cystic fibrosis patients including those with decreased susceptibility to Ceftaroline

2018-05-10

Abstract excerpt

<h4>ABSTRACT</h4> Methicillin-resistant Staphylococcus aureus (MRSA) acquisition in cystic fibrosis (CF) patients confers a worse clinical outcome with increased rate of declined lung function. Telavancin, an approved lipoglycopeptide used to treat infections due to S. aureus has a dual mode of action causing inhibition of the peptidoglycan synthesis and membrane depolarization. CF-associated MRSA infections re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c651071e-4f74-5981-8d77-32712fdb6634
DOI
10.1101/319210
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Activity of Telavancin against <i>S. aureus</i> isolated from cystic fibrosis patients including those with decreased susceptibility to CeftarolineDOI 10.1101/319210
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogensSemantic proximity
Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing MethodSemantic proximity
Parallel Evolution of Linezolid Resistant <i>Staphylococcus aureus</i> in Patients with Cystic FibrosisSemantic proximity
Clinically-relevant altered antibiotic responses and mechanisms of β-lactam sensitization of MRSA in cystic fibrosis artificial sputumSemantic proximity
Characterization of Staphylococcus aureus Strains Isolated from Czech Cystic Fibrosis Patients: High Rate of Ribosomal Mutation Conferring Resistance to MLS(B) Antibiotics as a Result of Long-Term and Low-Dose Azithromycin Treatment.Semantic proximity
Methicillin resistance and vancomycin heteroresistance in Staphylococcus aureus in cystic fibrosis patients.Semantic proximity
Antimicrobial Activity of <i>Lacticaseibacillus rhamnosus </i>CRL 2244 Extracts Against Community- and Hospital-Acquired <i>Staphylococcus aureus</i>Semantic proximity
Lasso peptides sviceucin and siamycin I have anti-virulence activity and restore vancomycin effectiveness in vancomycin-resistant <i>Enterococcus</i> sp. and <i>Staphylococcus aureus</i>Semantic proximity
The Antimicrobial Activity of <i>Pechuel-Loeschea leubnitziae</i> Leaf Extract and its Effect on The Expression Level of Methicillin Resistant <i>Staphylococcus Aureus</i> and <i>Candida albicans</i> Virulence-Associated GenesSemantic proximity
Antimicrobial activity of the quinoline derivative HT61, effective against non-dividing cells, in <i>Staphylococcus aureus</i> biofilmsSemantic proximity
The Cystic Fibrosis treatment, Trikafta, affects growth, viability, and cell wall of <i>Aspergillus fumigatus</i> biofilmsSemantic proximity
First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapySemantic proximity
Select a neighboring publication to make it the new centre.